Timothy Chen

TL;DR: Five patients relapsed in the brain, all associated with chest failure, and quality control analysis, including dosimetric reconstruction and port film review was introduced after the protocol was activated and was retrospectively applied.

TL;DR: The currently accepted staging system for small cell lung cancer considers patients who present with a pleural effusion as having extensive disease, but no series of such patients has been reported as discussed by the authors.

TL;DR: Although not statistically significant, the survival and response rates of patients in the combined levamisole arms were shorter than those of patients with limited squamous cell carcinoma of the lung in the combination of chemotherapy, immunotherapy, and performance status.

TL;DR: It appears that BCG immunotherapy has no beneficial effect on response rate, duration of response, or survival in programs using chemotherapy and radiotherapy for control of limited small‐cell carcinoma of the lung except in this small group of long‐term survivors.

TL;DR: In this article, the authors compared radiotherapy to the chest (RC) in disseminated small cell lung carcinoma (SCLC) and concluded that a dose of 3000 rad in two weeks seems to be enough to produce a low percentage of chest relapse.